0867.HK - China Medical System Holdings Limited
| Previous Close | 10.500 |
| Open | 10.920 |
| Bid | 9.160 x 0 |
| Ask | 9.170 x 0 |
| Day's Range | 8.990 - 10.920 |
| 52 Week Range | 8.530 - 20.000 |
| Volume | 17,097,000 |
| Avg. Volume | 5,841,235 |
| Market Cap | 22.743B |
| Beta (3Y Monthly) | 0.98 |
| PE Ratio (TTM) | 11.35 |
| EPS (TTM) | 0.807 |
| Earnings Date | Aug 20, 2018 - Aug 24, 2018 |
| Forward Dividend & Yield | 0.35 (3.52%) |
| Ex-Dividend Date | 2018-09-10 |
| 1y Target Est | 17.07 |
- Simply Wall St.•yesterday
Does China Medical System Holdings Limited’s (HKG:867) P/E Ratio Signal A Buying Opportunity?
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). To keep it practical, we’ll show how China Medical System Holdings Read More...
- Simply Wall St.•last month
Could China Medical System Holdings Limited’s (HKG:867) Investor Composition Impacts Your Returns?
A look at the shareholders of China Medical System Holdings Limited (HKG:867) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller, companies Read More...
- Reuters•2 months ago
BRIEF-China Medical System Through Unit Signs License And Collaboration Agreement With VAXIMM AG
Sept 19 (Reuters) - China Medical System Holdings Ltd : * GROUP THROUGH UNIT SIGNED LICENSE AND COLLABORATION AGREEMENT WITH VAXIMM AG * UNDER DEAL, GROUP GAINS EXCLUSIVE RIGHTS TO DEVELOP, COMMERCIALIZE ...
- Simply Wall St.•2 months ago
With An ROE Of 22.9%, Has China Medical System Holdings Limited’s (HKG:867) Management Done Well?
This article is intended for those of you who are at the beginning of your investing journey and want to start learning about core concepts of fundamental analysis on practicalRead More...
- Reuters•3 months ago
BRIEF-China Medical System Holdings Says It Entered Framework Asset Transfer Agreement With A&B
Aug 20 (Reuters) - China Medical System Holdings Ltd : * THROUGH UNIT ENTERED FRAMEWORK ASSET TRANSFER AGREEMENT WITH A&B (HK) CO FOR PHARMACEUTICAL PREPARATION AMONG OTHERS Source text for Eikon: Further ...
- Reuters•3 months ago
BRIEF-China Medical System Updates On Asset Purchase of Blueberry Therapeutics' Product Portfolio
Aug 14 (Reuters) - China Medical System Holdings Ltd : * GROUP ACQUIRED ALL RELATED ASSETS OF BLUEBERRY THERAPEUTICS' LEADING PRODUCT BB2603 IN CHINA, KOREA AND MONGOLIA * FURTHER ACQUIRED ACCESS TO ALL ...
- Reuters•3 months ago
BRIEF-China Medical System Holdings Says It Signed License, Collaboration & Distribution Agreement
Aug 6 (Reuters) - China Medical System Holdings Ltd : * THROUGH UNIT SIGNED A LICENSE, COLLABORATION AND DISTRIBUTION AGREEMENT WITH CAN-FITE BIOPHARMA LTD Source text for Eikon: Further company coverage:...
- Reuters•3 months ago
BRIEF-China Medical System Holdings Says Acquired All Assets Related To Acticor Biotech's Product ACT017
July 31 (Reuters) - China Medical System Holdings Ltd : * ACQUIRED ALL ASSETS RELATED TO ACTICOR BIOTECH'S PRODUCT ACT017 AND ANY FOLLOW-UP PRODUCTS DEVELOPED ON BASIS OF SAME Source text for Eikon: Further ...
- Reuters•4 months ago
BRIEF-China Medical System Announces Asset Purchase of Venus Pharma’s Product Portfolio
July 20 (Reuters) - China Medical System Holdings Ltd : * GROUP ACQUIRED ALL ASSETS OF VENUS PHARMA'S CURRENT PRODUCT PORTFOLIO RELATED TO MARKET IN CHINA Source text for Eikon: Further company coverage:...
- Reuters•5 months ago
BRIEF-China Medical System Holdings Says Unit Entered Agreement With Asahi Kasei Pharma Corporation
June 28 (Reuters) - China Medical System Holdings Ltd : * UNIT ENTERED BUSINESS PROMOTION DELEGATION AGREEMENT WITH ASAHI KASEI PHARMA CORPORATION FOR ELCITONIN * PURSUANT TO DEAL, UNIT GAINS EXCLUSIVE ...
- Simply Wall St.•5 months ago
China Medical System Holdings Limited (HKG:867) Is Trading At A 23.18% Discount
In this article I am going to calculate the intrinsic value of China Medical System Holdings Limited (HKG:867) by taking the expected future cash flows and discounting them to today’sRead More...
- Reuters•6 months ago
BRIEF-China Medical System Says Trading In Shares Will Resume On May 9
May 9 (Reuters) - China Medical System Holdings Ltd : * TRADING IN SHARES OF CO WILL BE RESUMED AT 9:00 A.M. ON MAY 9 Source text for Eikon: Further company coverage:
- Reuters•6 months ago
BRIEF-China Medical System Holdings Trading In Shares Halted
May 7 (Reuters) - China Medical System Holdings Ltd : * TRADING IN SHARES HALTED AT 9:07 A.M. ON MAY 7 Source text for Eikon: Further company coverage:
- Simply Wall St.•7 months ago
At $18.72, Is China Medical System Holdings Limited (HKG:867) A Buy?
China Medical System Holdings Limited (SEHK:867), a pharmaceuticals company based in China, saw a significant share price rise of over 20% in the past couple of months on the SEHK.Read More...
- Simply Wall St.•7 months ago
Top SEHK Growth Stocks To Buy
High-growth stocks that are financially stable are attractive for many reasons. They provide a strong upside to your portfolio, with less likelihood of downside risks compared to less financially robustRead More...
- Reuters•8 months ago
BRIEF-China Medical System Posts FY Profit Attributable Of RMB1.67 Bln
March 19 (Reuters) - China Medical System Holdings Ltd : * FY TURNOVER UP 9.1% TO RMB5,348.8 MILLION * PROPOSED FINAL DIVIDEND OF RMB0.1393 PER SHARE * FY PROFIT ATTRIBUTABLE RMB1,669.9 MILLION VERSUS ...
- Simply Wall St.•8 months ago
Top Growth Stocks To Buy Now
Looking to enhance your portfolio with high-growth, financially-robust stocks, but not sure where you should even begin? Stocks such as Central China Real Estate and China Medical System Holdings areRead More...
- Simply Wall St.•10 months ago
January Growth Opportunities – BBI Life Sciences And More
Stocks that are expected to significantly grow their profitability in the future can add meaningful upside to your portfolio. BBI Life Sciences and YiChang HEC ChangJiang Pharmaceutical are examples ofRead More...
